Search
Sulfasymazine
go.drugbank.com/drugs/DB21451ExperimentalSulfasymazine is a small molecule drug. Sulfasymazine has a monoisotopic molecular weight of 307.11 Da.
Ervogastat
go.drugbank.com/drugs/DB21489ExperimentalErvogastat is a small molecule drug. Ervogastat has a monoisotopic molecular weight of 407.16 Da.
Amelenodor
go.drugbank.com/drugs/DB21563ExperimentalAmelenodor is a small molecule drug. Amelenodor has a monoisotopic molecular weight of 399.16 Da.
Vulolisib
go.drugbank.com/drugs/DB21567ExperimentalVulolisib is a small molecule drug. Vulolisib has a monoisotopic molecular weight of 423.12 Da.
Teprosulvose
go.drugbank.com/drugs/DB21738ExperimentalTeprosulvose is a small molecule drug. Teprosulvose has a monoisotopic molecular weight of 568.33 Da.
Suvadronabinol
go.drugbank.com/drugs/DB21741ExperimentalSuvadronabinol is a small molecule drug. Suvadronabinol has a monoisotopic molecular weight of 513.31 Da.
Nitrous acid
go.drugbank.com/drugs/DB09112ApprovedInvestigationalIt is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic health system.
Categories: Compounds used in a research, industrial, or household settingClidinium
go.drugbank.com/drugs/DB00771ApprovedClidinium is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract.
Synonyms: Bromuro de clidinio, Bromure de ClidiniumMixtures: AA PHARMA CHLORAX CAPSULESelenious acid
go.drugbank.com/drugs/DB11127ApprovedSelenious acid is the acid form of sodium selenite, a form of selenium [L1910]. Selenium is an essential trace element and antioxidant. It is a cofactor metabolic enzyme regulation. … One study showed efficacy in the prevention of malignancy while utilizing a selenium supplement in humans.
Mixtures: One Per Day Vitamin and Mineral Dietary SupplementMitomycin
go.drugbank.com/drugs/DB00305ApprovedInvestigational[L12867,A193419] It is an alkylating agent that inhibits DNA synthesis (and, at higher concentrations, RNA and protein synthesis) by cross-linking the complementary strands of the DNA double helix. … [A193419] Mitomycin's cross-linking activity has resulted in its approval for the treatment of a variety of cancers - the most recent of which is an April 2020 approval for its use in low-grade Upper
Categories: Compounds used in a research, industrial, or household setting